INNOVATE BIOPHARMACEUTICLS I INNT
COM PAR · Common Stock · CUSIP 45782F105
1
institutional holders
-23 vs Q1 2020
$0reported value*
0 new
0 added
1 reduced
23 sold out
net sold ≈ $843.7k (-1.7m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 22 |
| Q1 2020 | 24 |
| Q2 2020 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 9 | 7 |
| Q2 2020 | 0 | 24 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q4 2019 | $0 | $8.0k | — |
| Q1 2020 | $56.0k | $8.0k | 0.14 |
| Q2 2020 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -721.0k |
| BlackRock Inc. | Sold out | -355.2k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -225.4k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -114.0k |
| CITADEL ADVISORS LLC | Sold out | -51.1k |
| NORTHERN TRUST CORP | Sold out | -41.2k |
| Summit X, LLC | Sold out | -34.0k |
| Ashfield Capital Partners, LLC | Sold out | -33.4k |
| Heritage Wealth Advisors | Sold out | -30.0k |
| RBC Europe Ltd | Sold out | -25.0k |
Holders, Q2 2020
| Manager | Shares | Change |
|---|---|---|
| IFP Advisors, Inc 0.00% of their portfolio | 0 $0 | Reduced -20 |